Do you want to read an article? Please log in or register.
Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients
Respiratory Tract Infection
RECOMMENDED
Related content
RECOMMENDED
Further Publications
Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Dickson RP, Schultz MJ, van der Poll T, Schouten LR, Falkowski NR, Luth JE, Sjoding MW, Brown CA, Chanderraj R, Huffnagle GB, Bos LDJ, BASIC Consortium
doi: 10.1164/rccm.201907-1487OC.
COMMENTED
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
Lancet Respir Med.
Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, Lagrou K, Verweij PE, Van de Veerdonk FL, Gommers D, Spronk P, Bergmans DCJJ, Hoedemaekers A, Andrinopoulou ER, van den Berg CHSB, Juffermans NP, Hodiamont CJ, Vonk AG, Depuydt P, Boelens J, Wauters J, Dutch-Belgian Mycosis study group
doi: 10.1016/
RECOMMENDED
Interstitial Lung Disease
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Eur Respir J.
Jacob J, Hirani N, van Moorsel CHM, Rajagopalan S, Murchison JT, van Es HW, Bartholmai BJ, van Beek FT, Struik MHL, Stewart GA, Kokosi M, Egashira R, Brun AL, Cross G, Barnett J, Devaraj A, Margaritopoulos G, Karwoski R, Renzoni E, Maher TM, Wells AU
doi: 10.1183/13993003.00869-2018.
Pulmonary Fibrosis
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
Lancet Respir Med.
Herazo-Maya JD, Sun J, Molyneaux PL, Li Q, Villalba JA, Tzouvelekis A, Lynn H, Juan-Guardela BM, Risquez C, Osorio JC, Yan X, Michel G, Aurelien N, Lindell KO, Klesen MJ, Moffatt MF, Cookson WO, Zhang Y, Garcia JGN, Noth I, Prasse A, Bar-Joseph Z, Gibson KF, Zhao H, Herzog EL, Rosas IO, Maher TM, Kaminski N
doi: 10.1016/
COPD
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
Lancet Respir Med.
Gedebjerg A, Szépligeti SK, Wackerhausen LH, Horváth-Puhó E, Dahl R, Hansen JG, Sørensen HT, Nørgaard M, Lange P, Thomsen RW2
doi: 10.1016/
Interstitial Lung DiseasePulmonary Fibrosis
Pulmonary vascular resistance estimated by Doppler echocardiography predicts mortality in patients with interstitial lung disease
J Cardiol.
Yasui K, Yuda S, Abe K, Muranaka A, Otsuka M, Ohnishi H, Hashimoto A, Takahashi H, Tsuchihashi K, Takahashi H, Takahashi S, Miura T.
doi: 10.1016/j.jjcc.2016.02.025
RECOMMENDED
EmphysemaPneumoniaPulmonary Hypertension
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Heart Lung Transplant
Nathan SD, Cottin V, Behr J, Hoeper MM, Martinez FJ, Corte TJ, Keogh AM, Leuchte H, Mogulkoc N, Ulrich S, Wuyts WA, Yao Z, Ley-Zaporozhan J, Müller-Lisse UG, Scholle FD, Brüggenwerth G, Busse D, Nikkho S, Wells AU
doi: 10.1016/j.healun.2021.02.006
Patient outcomes after transcatheter and surgical pulmonary valve replacement for pulmonary regurgitation in patients with repaired tetralogy of Fallot: A quasi-meta-analysis
Eur J Cardiovasc Nurs.
McRae ME, Coleman B, Atz TW, Kelechi TJ
doi: 10.1177/1474515117696384.
Interstitial Lung DiseasePulmonary Fibrosis
Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients with Interstitial Lung Disease
Chest
Cutting C, Bowman WS, Dao N, Pugashetti JV, Garcia CK, Oldham JM, Newton CA
doi: 10.1016/j.chest.2021.01.026